Literature DB >> 19799808

[A clinical verification of the Chinese 2008 staging system for nasopharyngeal carcinoma].

Yan-Ping Mao1, Wen-Fei Li, Lei Chen, Ying Sun, Li-Zhi Liu, Ling-Long Tang, Su-Mei Cao, Ai-Hua Lin, Ming-Huang Hong, Tai-Xiang Lu, Meng-Zhong Liu, Li Li, Jun Ma.   

Abstract

BACKGROUND AND
OBJECTIVE: The Chinese 2008 staging system for nasopharyngeal carcinoma (NPC) was a common set of recommendations by initial revision of the previous'92 staging system. This study was to verify the Chinese 2008 staging system and to provide evidence for its further revision.
METHODS: Between January 2003 and December 2004, 924 consecutive patients with newly diagnosed, nondisseminated biopsy-proven NPC, presented at the Department of Radiation Oncology, Cancer Center, Sun Yat-sen University, were entered into our study. All patients received magnetic resonance imaging examination of the neck and nasopharynx before treatment. According to the principle of the staging system, the indices of hazard consistency, hazard discrimination, prognostic value, and distribution were used to evaluate the Chinese 2008 staging system.
RESULTS: According to the Chinese 2008 staging system, the distribution of stage group for the whole series was 4.9% for the stage I, 22.6% stage II, 38.0% stage III, and 34.5% stage IVA. As for hazard discrimination, the 4-year local relapse-free survival (LRFS) rates for T1-T4 patients were 95.4%, 93.7%, 90.5% and 79.1%, respectively. Although the separation of LRFS for all subclassifications of T-stage showed reasonable, the differences among the subgroups T1, T2, and T3 were still lack of significant statistically. The 4-year distant metastasis failure-free survival (DMFS) rates for N0-N3 patients were 89.4%, 84.3%, 73.6, and 59.2%, respectively. The 4-year overall survival (OS) rates for stage I-IV patients were 96.7%, 94.1%, 82.6% and 67.1%, respectively. As for hazard consistency, the distinctions between T3 with skull base involvement and T3 with medial pterygoid muscle in the hazard ratios of local failure (1.628 vs. 3.905) and disease failure (1.630 vs. 3.288) were large. Multivariate analyses showed that cervical nodal level, extranodal neoplastic spread, and laterality were independent prognostic factors for OS and DMFS, but maximal axial diameter was not.
CONCLUSION: Using the Chinese 2008 staging system for NPC produces an acceptable distribution of patient numbers. Stage group, T classification, and N classification represent independent prognosis factors for major endpoints. However, our study reveals several deficiencies in the current system yet.

Entities:  

Mesh:

Year:  2009        PMID: 19799808     DOI: 10.5732/cjc.009.10425

Source DB:  PubMed          Journal:  Ai Zheng


  14 in total

1.  Magnetic resonance imaging staging of nasopharyngeal carcinoma in the head and neck.

Authors:  Ann Dorothy King; Kunwar Suryaveer Singh Bhatia
Journal:  World J Radiol       Date:  2010-05-28

2.  Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma.

Authors:  Xiong Liu; Hua-Nan Luo; Wen-Dong Tian; Juan Lu; Gang Li; Lu Wang; Bao Zhang; Bi-Jun Liang; Xiao-Hong Peng; Shao-Xiong Lin; Ying Peng; Xiang-Ping Li
Journal:  Cancer Biol Ther       Date:  2013-08-23       Impact factor: 4.742

3.  Incidence and mortality trends of nasopharynx cancer from 1990 to 2019 in China: an age-period-cohort analysis.

Authors:  Ruhai Bai; Jianzhong Sun; Yan Xu; Zhonghe Sun; Xiaoyan Zhao
Journal:  BMC Public Health       Date:  2022-07-15       Impact factor: 4.135

4.  miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma.

Authors:  Min Deng; Qiurong Ye; Zailong Qin; Ying Zheng; Wei He; Hailin Tang; Yanhong Zhou; Wei Xiong; Ming Zhou; Xiaoling Li; Qun Yan; Jian Ma; Guiyuan Li
Journal:  Tumour Biol       Date:  2013-03-13

5.  An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma.

Authors:  Zhaohui Luo; Liyang Zhang; Zheng Li; Xiayu Li; Gang Li; Haibo Yu; Chen Jiang; Yafei Dai; Xiaofang Guo; Juanjuan Xiang; Guiyuan Li
Journal:  BMC Med Genomics       Date:  2012-01-19       Impact factor: 3.063

6.  Prognostic value of classifying parapharyngeal extension in nasopharyngeal carcinoma based on magnetic resonance imaging.

Authors:  Guo-Yi Zhang; Ying Huang; Xue-Feng Hu; Xiang-Ping Chen; Tao Xu; Li-Zhi Liu; Wei-Hong Wei; Guo-Sen Huang; Miao-Miao Zhou; Ze-Li Huang; Yue-Jian Wang
Journal:  Biomed Res Int       Date:  2015-03-26       Impact factor: 3.411

Review 7.  The prevalence and prevention of nasopharyngeal carcinoma in China.

Authors:  Su-Mei Cao; Malcolm J Simons; Chao-Nan Qian
Journal:  Chin J Cancer       Date:  2011-02

8.  A new T classification based on masticator space involvement in nasopharyngeal carcinoma: a study of 742 cases with magnetic resonance imaging.

Authors:  Dong-Hua Luo; Jing Yang; Hui-Zhi Qiu; Ting Shen; Qiu-Yan Chen; Pei-Yu Huang; Rui Sun; Chao-Nan Qian; Hai-Qiang Mai; Xiang Guo; Hao-Yuan Mo
Journal:  BMC Cancer       Date:  2014-09-04       Impact factor: 4.430

9.  Should All Nasopharyngeal Carcinoma with Paranasal Sinus Invasion Be Staged as T3 in the Intensity-Modulated Radiotherapy Era? A Study of 1811 Cases.

Authors:  Yuan Zhang; Hao Peng; Rui Guo; Wen-Fei Li; Lei Chen; Xu Liu; Ling-Long Tang; Li-Zhi Liu; Li Li; Qing Liu; Ying Sun; Jun Ma
Journal:  J Cancer       Date:  2016-06-28       Impact factor: 4.207

10.  A novel statistical prognostic score model that includes serum CXCL5 levels and clinical classification predicts risk of disease progression and survival of nasopharyngeal carcinoma patients.

Authors:  Haibo Zhang; Weixiong Xia; Xing Lu; Rui Sun; Lin Wang; Lisheng Zheng; Yanfang Ye; Yingna Bao; Yanqun Xiang; Xiang Guo
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.